Back to Screener

Healthcare

Keros Therapeutics, Inc.(KROS)

Live Price

Offline

$10.98

+3.10% today

1Y Change

-26.24%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$430.00M
Revenue Growth
+6775.0%
EPS Growth
+146.8%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Keros Therapeutics, Inc. (KROS) is a Healthcare stock with a market cap of $430.00M and listed on NASDAQ. The stock last traded around $10.98 and down 26.2% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +6775.0%, EPS growth of +146.8%, a dividend yield of 0.0%. What stands out right now is revenue +6775.0%, EPS +146.8%, free cash flow +165.1% with operating margin 28.9% and ROIC 20.9%. Valuation is more restrained than many high-expectation growth names at P/E 4.9 and price/sales 1.7. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines KROS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

KROS

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

KROS Max Drawdown

-54.62%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for KROS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsAug 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 5, 26
TBD
โ€”
Est -1.33
โ€”
โ€”
Est 807.1B
โ€”
Aug 5
โ€”
May 14, 26
โœ—
-1.21
Est -0.92
-31.5%
367.0B
Est 1928.6B
-81.0%
May 14
โ€”
Mar 4, 26
โœ—
-0.86
Est -0.49
-75.5%
385.0B
Est 3665.5B
-89.5%
Mar 4
โ€”
Nov 5, 25
โœ“
-0.18
Est -1.11
+83.8%
14262.0B
Est 3662.5B
+289.4%
Nov 5
โ€”
Aug 6, 25
โœ“
-0.76
Est -1.14
+33.3%
18168.0B
Est 3210.6B
+465.9%
Aug 6
โ€”
May 6, 25
โœ“
3.62
Est -0.01
+36300.0%
211246.0B
Est 56645.4B
+272.9%
May 6
โ€”
Feb 26, 25
โœ“
-1.14
Est -1.36
+16.2%
3042.0B
Est 22233.3B
-86.3%
Feb 26
โ€”
Nov 6, 24
โœ—
-1.41
Est -1.26
-11.9%
388.0B
Est 2310.0B
-83.2%
Nov 6
โ€”
Aug 7, 24
โœ—
-1.25
Est -1.23
-1.6%
37.0B
Est โ€”
โ€”
Aug 7
โ€”
May 8, 24
โœ“
-1.21
Est -1.31
+7.6%
83.0B
Est โ€”
โ€”
May 8
โ€”
Feb 28, 24
โœ“
-1.34
Est -1.38
+2.9%
143.0B
Est โ€”
โ€”
Feb 28
โ€”
Nov 6, 23
โœ“
-1.33
Est -1.34
+0.8%
8.0B
Est โ€”
โ€”
Nov 6
โ€”
Aug 7, 23
โœ“
-1.27
Est -1.34
+5.2%
โ€”
Est 160.0B
โ€”
Aug 7
โ€”
May 4, 23
โœ—
-1.26
Est -1.13
-11.5%
โ€”
Est 220.0B
โ€”
May 4
โ€”
Mar 3, 23
โœ“
-1.09
Est -1.12
+2.7%
โ€”
Est 1200.0B
โ€”
Mar 3
โ€”
Nov 3, 22
โœ“
-0.92
Est -1.26
+27.0%
โ€”
Est โ€”
โ€”
Nov 3
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener